Consequently, tumor cells with hyperlactylated MRE11/NBS1 display marked chemoresistance, and pharmacologic blockade of lactate production (via LDHA inhibition) restores therapeutic sensitivity (65, 66). Here, MRE11 is linked to neoplasm.